Similarities in sunlight-induced mutational spectra of CpG-methylated transgenes and the p53 gene in skin cancer point to an important role of 5-methylcytosine residues in solar UV mutagenesis11Edited by J. Miller

2001 ◽  
Vol 305 (3) ◽  
pp. 389-399 ◽  
Author(s):  
Young-Hyun You ◽  
Gerd P Pfeifer
2006 ◽  
Vol 26 (22) ◽  
pp. 8515-8526 ◽  
Author(s):  
Judith Jans ◽  
George A. Garinis ◽  
Wouter Schul ◽  
Adri van Oudenaren ◽  
Michael Moorhouse ◽  
...  

ABSTRACT Cyclobutane pyrimidine dimers (CPDs) and 6-4 photoproducts (6-4PPs) comprise major UV-induced photolesions. If left unrepaired, these lesions can induce mutations and skin cancer, which is facilitated by UV-induced immunosuppression. Yet the contribution of lesion and cell type specificity to the harmful biological effects of UV exposure remains currently unclear. Using a series of photolyase-transgenic mice to ubiquitously remove either CPDs or 6-4PPs from all cells in the mouse skin or selectively from basal keratinocytes, we show that the majority of UV-induced acute effects to require the presence of CPDs in basal keratinocytes in the mouse skin. At the fundamental level of gene expression, CPDs induce the expression of genes associated with repair and recombinational processing of DNA damage, as well as apoptosis and a response to stress. At the organismal level, photolyase-mediated removal of CPDs, but not 6-4PPs, from the genome of only basal keratinocytes substantially diminishes the incidence of skin tumors; however, it does not affect the UVB-mediated immunosuppression. Taken together, these findings reveal a differential role of basal keratinocytes in these processes, providing novel insights into the skin's acute and chronic responses to UV in a lesion- and cell-type-specific manner.


Author(s):  
Alessandra Carè ◽  
Isabella Parolini ◽  
Federica Felicetti ◽  
Massimo Sargiacomo
Keyword(s):  

2005 ◽  
Vol 52 (2) ◽  
pp. 321-328 ◽  
Author(s):  
Tomasz Stokłosa ◽  
Jakub Gołab

The p53 tumor suppressor plays the role of a cellular hub which gathers stress signals such as damage to DNA or hypoxia and translates them into a complex response. p53 exerts its action mainly as a potent transcription factor. The two major outcomes of p53 activity are highlighted: cell cycle arrest and apoptosis. During malignant transformation p53 or p53-pathway related molecules are disabled extremely often. Mutations in p53 gene are present in every second human tumor. A mutant form of p53 may not only negate the wild type p53 function but may play additional role in tumor progression. Therefore p53 represents a relatively unique and specific target for anticancer drug design. Current approaches include several different molecules able to restore p53 wild-type conformation and activity. Such small molecule drugs hold great promise in treating human tumors with dysfunction of p53 pathway in the near future.


Cureus ◽  
2020 ◽  
Author(s):  
Paramvijay Singh Dhalla ◽  
Arunima Kaul ◽  
Jian Garcia ◽  
Anusha Bapatla ◽  
Raheela Khalid ◽  
...  

1998 ◽  
Vol 16 ◽  
pp. S50 ◽  
Author(s):  
Chikako Nishigori ◽  
Kanokvalai Kulthanan ◽  
Preya Kullavanijava ◽  
Hsin-Su yu ◽  
Sadao Imamura

2021 ◽  
Vol 9 (5) ◽  
pp. 202-204
Author(s):  
Amy Noakes

Sun exposure is the primary cause of skin cancer, and it has been suggested that most cases of melanoma could be prevented with greater understanding of sun damage and protection. Amy Noakes explains the vital role of sunscreen


Sign in / Sign up

Export Citation Format

Share Document